{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:54:45Z","timestamp":1790898885257,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacbts.2026.101661","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:51:11Z","timestamp":1787554271000},"page":"101661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Synergy and Inflammatory Activation in Pathogenesis and Therapy of Atrial Cardio-Metabolic Cardiomyopathy"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-7722","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Guichard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Nattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2026.101661_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae204","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.jacbts.2026.101661_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/antiox13010016","article-title":"Anti-inflammation and anti-oxidation: the key to unlocking the cardiovascular potential of SGLT2 inhibitors and GLP1 receptor agonists","volume":"13","author":"Myasoedova","year":"2023","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.jacbts.2026.101661_bib3","doi-asserted-by":"crossref","first-page":"101587","DOI":"10.1016\/j.jacbts.2026.101587","article-title":"Synergistic effects of SGLT2 inhibitors and GLP-1R agonists on inflammation-associated oxidative stress in atrial fibrillation","volume":"11","author":"Fakih","year":"2026","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101661_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167517","article-title":"Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation","volume":"133","author":"Song","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacbts.2026.101661_bib5","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/j.jtcvs.2022.03.013","article-title":"Impact of proinflammatory epicardial adipose tissue and differentially enhanced autonomic remodeling on human atrial fibrillation","volume":"165","author":"Zhao","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacbts.2026.101661_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","article-title":"Epicardial adipose tissue accumulation confers atrial conduction abnormality","volume":"76","author":"Nalliah","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101661_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf257","article-title":"Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials","author":"Cesaro","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101661_bib8","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/eurheartj\/ehag021","article-title":"Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis","volume":"47","author":"Raveendra","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101661_bib9","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101661_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacc.2017.06.033","article-title":"Atrial cardiomyopathy: a useful notion in cardiac disease management or a passing fad?","volume":"70","author":"Guichard","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:13:17Z","timestamp":1790896397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2452302X26001841"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101661","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Synergy and Inflammatory Activation in Pathogenesis and Therapy of Atrial Cardio-Metabolic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101587","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101661"}}